TEGSEDI

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug TEGSEDI contains one active pharmaceutical ingredient (API):

1 Inotersen UNII 950736UC77 - INOTERSEN SODIUM

Inotersen is an antisense oligonucleotide that causes degradation of mutant and wild-type TTR mRNA through binding to the TTR mRNA, which results in a reduction of serum TTR protein and TTR protein deposits in tissues. It is used for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR) in adults. Read about Inotersen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TEGSEDI Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX15		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 586020060000607, 586020060000707
Country: CA	Health Products and Food Branch	Identifier(s): 02481383
Country: EE	Ravimiamet	Identifier(s): 1778328, 1778339
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181296002
Country: FR	Base de données publique des médicaments	Identifier(s): 60789511
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 373338
Country: IT	Agenzia del Farmaco	Identifier(s): 046924015, 046924027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085961, 1085962
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100408465
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67656001, W67656002
Country: US	FDA, National Drug Code	Identifier(s): 72126-007